相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde et al.
CANCER RESEARCH (2011)
HIV controllers: A multifactorial phenotype of spontaneous viral suppression
Jacques Theze et al.
CLINICAL IMMUNOLOGY (2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells
Katarzyna Karwacz et al.
EMBO MOLECULAR MEDICINE (2011)
mRNA as gene therapeutic: How to control protein expression
Geertrui Tavernier et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
Genc Basha et al.
MOLECULAR THERAPY (2011)
Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner et al.
NATURE BIOTECHNOLOGY (2011)
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
Felipe Garcia et al.
VACCINE (2011)
siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
Willemijn Hobo et al.
BLOOD (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Lotte Engell-Noerregaard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
Pawel Kalinski et al.
FUTURE ONCOLOGY (2009)
siRNA Knockdown of PD-L1 and PD-L2 in Monocyte-Derived Dendritic Cells only Modestly Improves Proliferative Responses to Gag by CD8+ T Cells from HIV-1-Infected Individuals
Gaelle Breton et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Efficient Activation of LRH-1-specific CD8+ T-cell Responses From Transplanted Leukemia Patients by Stimulation With P2X5 mRNA-electroporated Dendritic Cells
Ingrid M. Overes et al.
JOURNAL OF IMMUNOTHERAPY (2009)
A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
James J. Lu et al.
MOLECULAR PHARMACEUTICS (2009)
Studies on mRNA electroporation of immature and mature dendritic cells:: Effects on their immunogenic potential
Oezcan Met et al.
MOLECULAR BIOTECHNOLOGY (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukeryiia
Ronjon Chakraverty et al.
BLOOD (2007)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia
BC Rijke et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses
P Reddy et al.
NATURE MEDICINE (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immunotherapy of cancer through targeting of minor histocompatibility antigens
L Hambach et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity
Y Zhang et al.
BLOOD (2004)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
VFI Van Tendeloo et al.
BLOOD (2001)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
分享论文
